IMCD Group B.V., the Netherlands-based leading company in sales, marketing and distribution of speciality chemicals and food ingredients, reported that its IMCD Italia S.p.a., has entered into an agreement with Organotec S r l to acquire their fine chemicals distribution in Italy. Organotec will be fully integrated into the IMCD Italia in January 2012.
“IMCD is continually looking to strategically expand its operations,” comments Gabriele Bonomi, managing director IMCD Italia. “Organotec is a reputable player in fine chemicals market in Italy and their portfolio perfectly complements ours in Italy. On the other hand, our expertise and network in other markets open up possibilities for Organotec’s principals to enter new market sectors. These are all the reasons that made IMCD and Organotec a perfect match.”
Organotec has twenty-five-year experience in the field of special organic chemical products, fine chemicals and their correlated technologies with main focus on pharmaceutical industry. With strong focus on R&D, they offer a wide range of highly specialised intermediates to be used both for existing and future synthesis involved in new projects of drugs and finished products of other fields. Most of Organotec’s principals are FDA approved, ISO certified and work under cGMP conditions.
With more than 60 pharma focused technical sales experts in over 20 countries, the IMCD Business Group Pharmaceuticals is the number 1 distributor of speciality pharmaceutical ingredients.
This is a third acquisition for IMCD Group this year, following Ethnichem in South Africa for the personal care and pharmaceutical markets and recent Infineum in Australia for the lubricants market.